| Page 40 | Cafepharma

You are here

Primary tabs

Genentech Announces New Data for Risdiplam in Spinal Muscular Atrophy in Infants

Post date: October 3, 2018 - 9:24am

GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment

Post date: October 2, 2018 - 9:58am

Clovis Oncology Receives Breakthrough Therapy Designation for Rubraca for Metastatic Castration Resistant Prostate Cancer

Post date: October 2, 2018 - 9:49am

Rebiotix to Present Data From First-In-Class Microbiota Restoration Therapy at IDWeek 2018

Post date: October 1, 2018 - 11:29pm

ADMA Biologics Resubmits BLA for Primary Immunodeficiency Disease Drug

Post date: October 1, 2018 - 10:00am

Seattle Genetics' and Takeda's Adcetris Meets Primary and Secondary Endpoints in Ph III Trial for T-Cell Lymphoma

Post date: October 1, 2018 - 9:28am

First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers

Post date: October 1, 2018 - 9:07am

KSQ Therapeutics Banks $80 Million in Series C Round

Post date: September 28, 2018 - 11:53am

Alnylam Submits NDA in Japan for Onpattro for Hereditary ATTR Amyloidosis

Post date: September 28, 2018 - 9:28am

Microbiome Report for Week Ending 9/22/18

Post date: September 27, 2018 - 10:59pm

Pages